Caricamento...
Gene Therapy for Immune Tolerance Induction in Hemophilia with Inhibitors
The development of inhibitors, neutralizing alloantibodies to Factor VIII (FVIII) or Factor IX (FIX), is the most significant complication of protein replacement therapy for patients with hemophilia and is associated with increased mortality as well as substantial physical, psychosocial, and financi...
Salvato in:
| Pubblicato in: | J Thromb Haemost |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4907803/ https://ncbi.nlm.nih.gov/pubmed/27061380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.13331 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|